Suchergebnisse

This book offers a frank, clear-eyed, no-holes-barred examination of drug abuse-from the most commonly abused drugs to how drug abuse begins and progresses to the dangerous and deadly consequences of drug abuse. It also charts the treacherous path by which "casual" drug use develops into addiction. Loaded with great questions to ask a drug counselor, common myths and facts about drug use and abuse, and resources for getting help for oneself or loved ones, this book is a potentially lifesaving aid and wakeup call for teens in peril, especially those who don't yet realize they're in peril

Intro -- Table of Contents -- Series Introduction -- Chapter One: What Are Prescription Drugs? -- Chapter Two: Painkillers -- Chapter Three: Sedatives and Hypnotics -- Chapter Four: Stimulants -- Further Reading -- Educational Videos -- Series Glossary -- Index -- About the Author -- About the Advisor -- Photo Credits.

Intro -- One Living Life To Do More Drugs -- Two Triggers And Thypical Warning Signs -- Three The Harm In Getting High -- Four An issue THat Impacts Relationships -- Five Getting Clean And Staying Sober -- Six Teens' Ideas on Tackling Drug Abuse -- Notes -- Glossary -- Further information -- Bibliography -- Index

Research on drug use often fails to account for drug dealing in most analyses of violence and other systemic risks associated with illegal drugs. The current study examined whether drug dealing, independent of its connection to drug use, increases involvement with delinquent peers, violence, weapons, and other drug-related conflicts. Data were drawn from the first two waves of the Toledo Adolescent Relationships Study ( N = 1,148). Hierarchical linear models were used to investigate changes in these behaviors that resulted from the respondents' involvement in drug dealing and drug use. Results indicate that involvement in drug dealing, controlling for drug use, increases violence and other systemic risks to a level that drug use alone is not likely to achieve. Findings also show, however, that drug use among dealers may reduce violence and limit contact with delinquent peers.

Public officials should compensate the victims of wrongful conviction and enforcement. The same considerations in favor of compensating people for wrongful conviction and enforcement in other cases support officials' payment of reparations to the victims of unjust enforcement practices related to the drug war. First, we defend the claim that people who are convicted and incarcerated because of an unjust law are wrongfully convicted. Although their convictions do not currently qualify as wrongful convictions in the legal sense, we argue that the same reasons for legally recognizing other wrongful convictions support conceiving of these cases as wrongful convictions. If so, then people who suffered wrongful convictions associated with unjust laws, like others who were wrongfully convicted, are entitled to compensation and reparation. We then argue that America's drug laws are unjust laws. Therefore, people who were convicted of nonviolent drug offenses are entitled to compensation.

"Taking a multidisciplinary perspective (including public health, sociology, criminology, and political science amongst others), and using examples from across the globe, this book provides a detailed understanding of the complex and highly contested nature of drug policy, drug policy making and the theoretical perspectives that inform the study of drug policy. It draws on four different theoretical perspectives: evidence-informed policy, policy process theories, democratic theory, and post-structural policy analysis. The use and trade in illegal drugs is a global phenomenon. It is viewed by governments as a significant social, legal, and health problem that shows no signs of abating. The key questions explored throughout this book are what governments and other bodies of social regulation should do about illicit drugs, including drug policies aimed at improving health and reducing harm, drug laws and regulation, and the role of research and values in policy development. Seeing policy formation as dynamic iterative interactions between actors, ideas, institutions, and networks of policy advocates, the book explores how policy problems are constructed and policy solutions selected, and how these processes intersect with research evidence and values. This then animates the call to democratise drug policy and bring about inclusive meaningful participation in policy development in order to provide the opportunity for better, more effective, and value-aligned drug policies. This book will be of great interest to students and scholars of drug policy from a number of disciplines, including public health, sociology, criminology, and political science"--

Conference Series has been instrumental in conducting international meetings for seven years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like Belgium, Tokyo, Madrid, with success the meetings again scheduled in three continents. It's time to announce 9th Annual Congress on Drug Formulation & Drug Design October 19-21, 2017 Seoul, South Korea . Drug Formulation 2017 is a 3-day event offering the Exhibition, at venue to showcase the research and development on emerging technologies and have wider sessions involving Keynote presentation, Oral, YRF ( student presentation), poster, e-poster presentations. This is an excellent platform to intensify collaborations for Professionals Scientific Experts and Industrial Delegates for Pharma field knowledge seekers. Global Pharmaceutical Industry in its operation and innovation activities is now facing serious challenges resulted by mega trends in healthcare paradigm. Korean R&D-based pharmaceutical companies have been involving in pioneering unmet medical needs areas investing over 65% to their annual net profit with the strong support from the Korean government. Modern pharmaceutical industry in Korea has 110 years of history initiating at the end of the 1800s, when a first modern pharmaceutical company began its operation. However, the South Korea region represents a significant growth opportunity for the Drug Formulation market during the forecast period of 2014 to 2019. Everyone interested in the future of emerging –drugs majorly in the field drug discovery, design, drug development, pharmacokinetic research, clinical pharmacology and new therapeutic drugs on recent developments in the field of generic drug research, current challenges and possibilities in modeling a new drug involving Drug Formulaton & Drug Design Reasearch Who to attend: CEOs, CROs, Directors, Managers and research associates in pharmaceutical industry in the drug or device industries (both innovator and generic) ...

Abstract Background Prescription writing is a process which transfers the therapeutic message from the prescriber to the patient through the pharmacist. Prescribing errors, drug duplication and potential drug-drug interactions (pDDI) in prescriptions lead to medication error. Assessment of the above was made in prescriptions dispensed at State Pharmaceutical Corporation (SPC), Anuradhapura, Sri Lanka. Methods A cross sectional study was conducted. Drugs were classified according to the WHO anatomical, therapeutic chemical classification system. A three point Likert scale, a checklist and Medscape online drug interaction checker were used to assess legibility, completeness and pDDIs respectively. Results Thousand prescriptions were collected. Majority were hand written (99.8 %) and from the private sector (73 %). The most frequently prescribed substance and subgroup were atorvastatin (4 %, n = 3668) and proton pump inhibitors (7 %, n = 3668) respectively. Out of the substances prescribed from the government and private sectors, 59 and 50 % respectively were available in the national list of essential medicines, Sri Lanka. Patients address (5 %), Sri Lanka Medical Council (SLMC) registration number (35 %), route (7 %), generic name (16 %), treatment symbol (48 %), diagnosis (41 %) and refill information (6 %) were seen in less than half of the prescriptions. Most were legible with effort (65 %) and illegibility was seen in 9 %. There was significant difference in omission and/or errors of generic name ( P = 0.000), dose ( P = 0.000), SLMC registration number ( P = 0.000), and in evidence of pDDI ( P = 0.009) with regards to the sector of prescribing. The commonest subgroup involved in duplication was non-steroidal anti-inflammatory drugs (NSAIDs) (43 %; 56/130). There were 1376 potential drug interactions (466/887 prescriptions). Most common pair causing pDDI was aspirin with losartan (4 %, n = 1376). Conclusion Atorvastatin was the most frequently prescribed substance. Fifteen percent of the prescriptions originate from government sector. SLMC registration number and trade names were seen more in prescriptions originating from the private sector. Most prescriptions were legible with effort. NSAIDs were the commonest implicated in drug class duplication. .

Cover -- Other Titles in the Investigate Drugs Series -- Title Page -- Copyright Page -- Contents -- Chapter 1: Danger in the Club -- Stories of Club Drug Abuse -- Past-Year Use of Illicit Drugs and Pharmaceuticals among 12th Graders -- DID YOU KNOW? Peer Pressure -- What You Need to Know -- DID YOU KNOW? The Number One Club Drug: Alcohol -- Chapter 2: MDMA/Ecstasy - A Night Out Turns Deadly -- Methyl-Who? -- Deceiving Looks -- This Is Your Brain on Drugs -- When You Can't Stop -- DID YOU KNOW? What's in This Stuff -- Chapter 3: Ketamine, Bad Medicine -- Keta-who? -- Abusing Ketamine -- DID YOU KNOW? Ketamine's a Real Downer -- When You Can't Stop -- How to Identify-and Avoid-Ketamine -- DID YOU KNOW? The Name Game -- Chapter 4: Crystal Meth - Shattered Lives -- DID YOU KNOW? Amphetamine -- Metham-what? -- A High That Kills -- When You Can't Stop -- The Price We All Pay -- DID YOU KNOW? The Name Game -- Chapter 5: GHB and ROHYPNOL - "Date Rape" Drugs -- GHB? -- Heather's Story: Rohypnol -- "Date Rape" Drugs -- So How Do You Know? -- Staying Safe -- DID YOU KNOW? Cracking Down -- DID YOU KNOW? The Name Game -- Assault Aside -- Chapter 6: LSD - A Bad Trip -- Lysergic-who? -- A Drug of All Shapes and Sizes -- Tripping -- DID YOU KNOW? LSD For Good? -- DID YOU KNOW? The Name Game -- When You Can't Stop -- Chapter 7: Getting Help -- Treatment for Drug Addiction -- DID YOU KNOW? Drug Schedules? -- DID YOU KNOW? Places to Go For Help -- DID YOU KNOW? Emergency Room Visits -- Chapter Notes -- Glossary -- For More Information -- Further Reading -- Internet Addresses -- Index -- Back Cover

Title from cover. ; Index to U.S. government periodicals ; Excerpta medica. ; Legal resource index ; Mode of access: Internet.